Global HIV Infection Drug Pipeline Analysis
MUMBAI, December 13, 2013 /PRNewswire/ --
Bharat Book Bureau presents Global HIV Infection Drug Pipeline Analysis. This report provides the discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retroviral in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have been successful in improving the quality of life for HIV patients and prevented the virus from developing into AIDS. The rate of HIV infection and the number of deaths due to AIDS has been on a declining note at a positive rate across the globe. It has been estimated that the death rate reduced from 2.3 million in 2005 to 1.6 in 2012, with the rates for children being even much lower. A major cause for such drastic changes in the infection rates has been the improved access to antiretroviral drugs and therapy in recent years.
(Logo: http://photos.prnewswire.com/prnh/20130128/590935 )
Bharat Book Bureau presents the report entitled "Global HIV Infection Drug Pipeline Analysis" (http://www.bharatbook.com/healthcare-market-research-reports/global-hiv-infection-drug-pipeline-analysis.html ) It gives comprehensive insight on the various drugs being developed for the treatment of HIV Infection. Research report covers all the ongoing drugs being developed in various clinical development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the HIV Infection drug market based upon development process.
Following parameters for each drug profile in clinical development phase are covered in "Global HIV Infection Drug Pipeline Analysis" research report:
- Drug Profile Overview
- Alternate Names for Drug
- Active Indication
- Phase of Development
- Mechanism of Action
- Brand Name
- Patent Information
- Orphan Designation by Indication, Country & Organization
- Country for Clinical Trial
- Owner / Originator/ Licensee/Collaborator
- Administrative Route
- Drug Class
- ATC Codes
HIV Infection Drug Development by Clinical Phase:
- Research: 31
- Preclinical: 140
- Phase-I: 53
- Phase-I/II: 18
- Phase-II: 39
- Phase-III: 7
- Preregistration: 2
- Registered: 2
- Marketed: 34
Table of Contents
- HIV Infection Drug Market Overview
- HIV Infection Drug Clinical Development Phase: Research
- Overview
- HIV Infection Drug Profiles in Clinical Phases
- HIV Infection Drug Clinical Development Phase: Preclinical
- Overview
- HIV Infection Drug Profiles in Clinical Phase
- HIV Infection Drug Clinical Development Phase: Phase-I
- Overview
- HIV Infection Drug Profiles in Clinical Phase
- HIV Infection Drug Clinical Development Phase: Phase-I/II
- Overview
- HIV Infection Drug Profiles in Clinical Phase
- HIV Infection Drug Clinical Development Phase: Phase-II
- Overview
- HIV Infection Drug Profiles in Clinical Phase
- HIV Infection Drug Clinical Development Phase: Phase-III
- Overview
- HIV Infection Drug Profiles in Clinical Phase
- HIV Infection Drug Clinical Development Phase: Preregistration
- Overview
- HIV Infection Drug Profiles in Clinical Phase
- HIV Infection Drug Clinical Development Phase: Registered
- Overview
- HIV Infection Drug Profiles in Clinical Phase
- Marketed Drugs
- Overview
- Marketed Drug Profile
Request for sample pages: http://www.bharatbook.com/RequestSample.asp?pid=430480
For more information on the report: http://www.bharatbook.com/healthcare-market-research-reports/global-hiv-infection-drug-pipeline-analysis.html
Related Reports:
- HIV-1 Infection - Pipeline Review, H2 2013
- 2014 Analysis of Cancer Diagnostic Technologies and Emerging Markets
- Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2013
- Infective Partnering Terms and Agreements
- The 2013-2018 World Outlook for HIV/AIDS Confirmatory Tests
Related Category:
About Bharat Book Bureau
Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.
Contact us:
Poonam
Bharat Book Bureau
USA/Canada - 1-866-279-8368 (Toll free)
India: +91-22-27810772, 27810773
Blog: http://blog.bharatbook.com
E: [email protected]
W: http://www.bharatbook.com
SOURCE Bharat Book Bureau
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article